About this episode
Professor Matthew Cobb looks at how genetic engineering became big business - from the first biotech company that produced human insulin in modified bacteria in the late 1970s to the companies like Monsanto which developed and then commercialised the first GM crops in the 1990s. Were the hopes and fears about these products of genetic engineering realised?
Thanks to The State of Things from North Carolina Public Radio WUNC for the interview with Mary-Dell Chilton.
(Picture: DNA molecule, Credit: KTSDesign/Science Photo Library/Getty Images)
Get every episode summarized
Each time Discovery publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
